Latest article
Zegalogue Authorised for Extreme Hypoglycemia in Sufferers With Diabetes
The Food and Drug Administration (FDA) has approved Zegalogue® (dasiglucagon) for the treatment of severe hypoglycemia in pediatric and adult patients with diabetes aged...
Adocia Initiates BC LisPram Part 1 Scientific Trial in Pump for Individuals with Kind...
Lyon, France - (BUSINESS WIRE) - Regulatory news:
Adocia (Euronext Paris: FR0011184241 - ADOC) (Paris: ADOC), a...